Clinical Trial Update: A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy [Phase 1, Phase 2]

View source ↗

Summary

This document announces a Phase 1/Phase 2 clinical trial evaluating MR001 in combination with chemotherapy for locally advanced or metastatic pancreatic ductal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• MR001

Snippet

Sponsor: Shenzhen Majory Biotechnology Co., Ltd. | Conditions: Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 1, Phase 2 | Status: RECRUITING